CLPT logo

CLPT
ClearPoint Neuro Inc

3,294
Mkt Cap
$350.88M
Volume
286,430.00
52W High
$30.10
52W Low
$8.27
PE Ratio
-11.61
CLPT Fundamentals
Price
$11.59
Prev Close
$11.70
Open
$11.76
50D MA
$10.59
Beta
2.16
Avg. Volume
486,907.07
EPS (Annual)
-$0.902
P/B
18.62
Rev/Employee
$214,947.67
$399.66
Loading...
Loading...
News
all
press releases
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for ClearPoint Neuro (CLPT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
News Placeholder
More News
News Placeholder
ClearPoint Neuro Q1 2026 Earnings Call Transcript
read more...
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -16.36% and -1.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates
Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of +34.78% and +3.46%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
ClearPoint Neuro (CLPT) to Release Quarterly Earnings on Wednesday
ClearPoint Neuro (NASDAQ:CLPT) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-clearpoint-neuro-inc-stock...
News Placeholder
UFP Technologies (UFPT) Tops Q1 Earnings Estimates
UFP (UFPT) delivered earnings and revenue surprises of +13.76% and -2.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3% - Should You Sell?
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3% - What's Next...
News Placeholder
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March
ClearPoint Neuro, Inc. (NASDAQ:CLPT - Get Free Report) saw a large growth in short interest in March. As of March 13th, there was short interest totaling 4,288,498 shares, a growth of 29.0% from the...
News Placeholder
ClearPoint Neuro Q4 Earnings Call Highlights
ClearPoint Neuro (NASDAQ:CLPT) reported higher revenue for both the fourth quarter and full year 2025 and outlined a two-phase growth strategy that management said is designed to expand the company's...
News Placeholder
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial
B. Riley Financial lifted their target price on shares of ClearPoint Neuro from $18.00 to $20.00 and gave the company a "buy" rating in a report on Wednesday...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available